Sulthiame clinical trials
Also written Ospolot.
Its developmentBy Shionogi and Desitin Arzneimittel, step by step2 company-led studies, furthest phase 2: when each phase was reached, its deals, target and what is ahead.How each study uses sulthiame is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the sulthiame studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
3 studies that test it; most in 2018 (1)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2021 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 1
Desitin Arzneimittel GmbH (1) · Centre Hospitalier Universitaire Vaudois (1) · Shionogi (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test sulthiame.
- Dec 2026Study of Sulthiame (S-054502) in Participants With Renal Impairment and Matched Healthy ControlsPhase 1 · Shionogi
Studies
Open first, then newest update. How each study uses sulthiame is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Study of Sulthiame (S-054502) in Participants With Renal Impairment and Matched Healthy ControlsNot yet recruitingPhase 1ShionogiNCT07857837Written as Sulthiame
- Efficacy, Safety and Tolerability of Sulthiame in Patients With Obstructive Sleep Apnea (OSA)CompletedPhase 2Desitin Arzneimittel GmbHNCT05236842Written as Sulthiame
- Pharmacokinetics and Tolerability of SulthiameCompletedPhase 1Centre Hospitalier Universitaire VaudoisNCT03400189Written as Sulthiame
Codes
What other systems call sulthiame · ClinicalTrials.gg INT003759
- MeSH (NLM) C084593sulthiameConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) I00Q766CZ2SULTHIAMEConfirmed FDA, NLM, Wikidata
- RxNorm 10240Confirmed FDA, Wikidata
- Wikidata Q2364943sulthiameConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C152469SulthiameOne source FDA
- DrugBank DB08329One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C084593 | sulthiame | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | I00Q766CZ2 | SULTHIAME | Confirmed FDA, NLM, Wikidata |
| RxNorm | 10240 | — | Confirmed FDA, Wikidata |
| Wikidata | Q2364943 | sulthiame | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C152469 | Sulthiame | One source FDA |
| DrugBank | DB08329 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.